Expanded Portfolio for Biomolecules Purification Announced
Oct 12 2017 Comments 0
With the increased interest in the purification of a wider variety of biomolecules, the portfolio of Kromasil 300 Å has been expanded to support these applications.
The Kromasil 300 Å line of HPLC products is now shipping with C18, C8, C4 and diC4 derivatisations for scientists and engineers exploiting selectivity and loadability for purification of API and impurity isolation. In particular, the new Kromasil 300 Å diC4 has different characteristic than a classic C4, enabling new opportunities to remove impurities from peptide and protein crudes.
For more information, visit www.kromasil.com
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In this Issue Asian Guide to Scientific Instruments & Chemicals A Comprehensive Bibliography of Who’s Who in the Laboratory and Analytical Science Industry The following guide has been pro...
View all digital editions
Oct 23 2017 Moscow, Russia
Oct 31 2017 New York, USA
Nov 05 2017 Jeju Island, Korea
Nov 07 2017 BioCity Scotland
Nov 12 2017 Minneapolis, MN, USA